In agreement with these results, Song et al. found that RCC2 was transcriptionally activated by P53 through activating the promoter of RCC2 in colon cancer, and P53 deficiency suppressed RCC2 expression (10). This evidence concerns the gene TP53 and malignant colon neoplasm.